Gentiae Clinical Research Completes Mortara Certified Partner Program For Digital ECG Submission To The FDA

Gentiae Clinical Research, Inc., a provider of centralized cardiac safety monitoring and imaging services, announced today their participation in and successful completion of Mortara Instrument's Certified Partner Program. This program rewards compliance to the HL7 annotated ECG standard required for submitting ECG datasets to the FDA. The datasets are routed through the ECG warehouse, which was developed by Mortara in collaboration with the FDA.

Back to news